Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sidney Keisner

Concepts (49)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bone Density Conservation Agents
2
2023
75
0.840
Why?
Bone Neoplasms
2
2023
184
0.770
Why?
Phenylthiohydantoin
1
2016
2
0.510
Why?
Warfarin
1
2016
82
0.470
Why?
Thrombosis
1
2016
252
0.410
Why?
Anticoagulants
1
2016
276
0.410
Why?
Ketoconazole
1
2010
10
0.340
Why?
Androgen Antagonists
1
2010
11
0.340
Why?
Carcinoma, Renal Cell
1
2011
112
0.320
Why?
Sulfonamides
1
2011
132
0.320
Why?
Proton Pump Inhibitors
1
2010
86
0.320
Why?
Pyrimidines
1
2011
198
0.310
Why?
Kidney Neoplasms
1
2011
182
0.310
Why?
Protein Kinase Inhibitors
1
2011
225
0.300
Why?
Antineoplastic Agents
1
2016
1214
0.280
Why?
Prostatic Neoplasms
1
2010
396
0.260
Why?
Drug Interactions
2
2016
201
0.200
Why?
Phthalazines
1
2022
20
0.190
Why?
Piperazines
1
2022
125
0.170
Why?
Indoles
1
2022
276
0.150
Why?
Prospective Studies
1
2023
2424
0.130
Why?
Retrospective Studies
3
2023
6610
0.130
Why?
Nitriles
1
2016
51
0.120
Why?
Benzamides
1
2016
50
0.120
Why?
Humans
6
2023
52114
0.120
Why?
Male
4
2022
26652
0.100
Why?
Controlled Clinical Trials as Topic
1
2011
21
0.090
Why?
Clinical Trials, Phase III as Topic
1
2011
48
0.090
Why?
Indazoles
1
2011
47
0.080
Why?
Prostate-Specific Antigen
1
2010
43
0.080
Why?
Drug Resistance
1
2010
68
0.080
Why?
Treatment Outcome
2
2011
5456
0.080
Why?
Diphosphonates
1
2011
92
0.080
Why?
Imidazoles
1
2011
123
0.080
Why?
Middle Aged
3
2016
13028
0.080
Why?
Disease-Free Survival
1
2010
462
0.080
Why?
Gastrointestinal Diseases
1
2010
126
0.080
Why?
Drug Therapy, Combination
1
2010
399
0.080
Why?
Aged, 80 and over
2
2011
3382
0.060
Why?
Acute Kidney Injury
1
2011
384
0.060
Why?
Aged
2
2011
10142
0.040
Why?
Animals
1
2011
13332
0.030
Why?
Creatinine
1
2011
158
0.020
Why?
Incidence
1
2011
1070
0.020
Why?
Dose-Response Relationship, Drug
1
2011
1368
0.020
Why?
Time Factors
1
2011
2970
0.010
Why?
Neoplasms
1
2011
1288
0.010
Why?
Adult
1
2011
14095
0.010
Why?
Female
1
2011
28055
0.010
Why?
Keisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description